Workshop on Oral, Gastrointestinal and Pulmonary GvHD€¦ · SCT-OUTPATIENT CLINIC St. Anna...
Transcript of Workshop on Oral, Gastrointestinal and Pulmonary GvHD€¦ · SCT-OUTPATIENT CLINIC St. Anna...
Program
Workshop
Workshop on Oral, Gastrointestinal and Pulmonary GvHD
November 17 – 18, 2017University Hospital RegensburgRegensburg, Germany
CME credits 7
Awarded with
3
Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
Scientific Program . . . . . . . . . . . . . . . . . . . . . . . . . 6
List of Speakers . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
7 credit hours (CME) have been awarded to the Workshop by the European Union of Medical Specialists (UEMS) – European Board of Gastroenterology (EBG).
4
Preface
Dear colleagues,
We are pleased to invite you to the Workshop on oral, gastrointestinal and pulmonary GvHD 2017 held in Regensburg. Acute and chronic GvHD continues to be associated with significant morbidity and mortality representing an ongoing challenge in clinical care. Recently, new insights in the pathophysiology of microbial changes associated with different organ GvHD (oral mucosa, gastrointestinal tract and lung) and their impact on immunoregulation have been achieved, their translation into clinical success remains challenging.
The workshop on oral, gastrointestinal & pulmonary GvHD will provide a comprehensive overview on pathophysiology including microbiological changes, and will provide an update on diagnosis, immunosuppressive and supportive treatment of the latter organ manifestations.
The workshop is supported by the Falk Foundation e.V.
E. Holler, M. Edinger, W. Herr, M. Evert, D. Weber, A. Gessner, D. Wolff (Regensburg, Germany)H. Greinix (Graz, Austria), A. Lawitschka (Vienna, Austria), J. Halter (Basel, Switzerland)G.C. Hildebrandt (Lexington, USA), S.Z. Pavletic (Bethesda, USA)
5
Workshop
Workshop on Oral, Gastrointestinal and Pulmonary GvHD
November 17 – 18, 2017University Hospital RegensburgRegensburg, Germany
Start of Registration:Friday, November 17, 201711.45 – 18.30 hat the congress offi ce
Congress Venue:University Hospital Regensburg-Großer Hörsaal-Franz-Josef-Strauß-Allee 1193053 RegensburgGermany
The Workshop is organized by Falk Foundation e.V.
Scientifi c Organization:Prof. Dr. Daniel WolffDepartment of Hematology and OncologyUniversity Hospital RegensburgFranz-Josef Strauss-Allee 1193053 Regensburg, GermanyTel: +49 (0)941-944-5531Fax: +49 (0)941-944-5543E-Mail: [email protected]
Scientifi c Co-Organization:H. Greinix, Graz (Austria)J. Halter, Basel (Switzerland)W. Herr, Regensburg (Germany)G.C. Hildebrandt, Lexington (USA)E. Holler, Regensburg (Germany)S.Z. Pavletic, Bethesda (USA)
Offi cial Language:English
6
Friday, November 17, 2017
12.45 Welcome W. Herr, Regensburg
Session I Pathophysiology of acute and chronic GvHD I
Chair: G.R. Hill, Brisbane; P.R. Reddy, Ann Arbor
13.00 Role of APC’s in GvHD G.R. Hill, Brisbane
13.30 Effector T cell programs in GvHD R. Chakraverty, London
14.00 Innate lymphoid cells in graft-versus-host disease M.-C. Brueggen, Zurich
14.20 CD4+CD25+ regulatory T cells in allogeneic stem M. Edinger, cell transplantation Regensburg
14.40 Coffee break
Session II Pathophysiology of acute and chronic GvHD II
Chair: R. Chakraverty, London; M. Edinger, Regensburg
15.00 The role of B cells in chronic GvHD T. Winkler, Erlangen
15.20 Innate immunity R. Zeiser, Freiburg
15.40 Role of antimicrobial peptides and Paneth cells J.L.M. Ferrara, New York
16.00 Pathophysiology of intestinal tolerance P.R. Reddy, Ann Arbor
16.30 Coffee break
7
Friday, November 17, 2017
Session III Lung GvHD
Chair: H. Greinix, Graz; A. Lawitschka, Vienna
17.00 Pathophysiology of lung GvHD G.C. Hildebrandt, Lexington
17.30 Diagnosis of lung GvHD J. Halter, Basel
18.00 Treatment of lung GvHD S.Z. Pavletic, Bethesda
18.30 End of afternoon session
8
Saturday, November 18, 2017
Session IV Oral GvHD
Chair: S. Elad, Rochester; D. Wolff, Regensburg
9.00 Microbiome in oral chronic GvHD M. Mravak-Stipetic, Zagreb
9.20 Immunosuppressive treatment of oral chronic GvHD S. Elad, Rochester
10.00 Supportive care E.M. Wagner, Mainz
10.20 Coffee break
Session V GI-GvHD
Chair: A. Gerbitz, Berlin; M.R.M. van den Brink, New York
10.50 Impact of microbiota in experimental GI-GvHD M.R.M. van den Brink, New York
11.20 Pathophysiology of microbial changes in clinical D. Weber, GI-GvHD Regensburg
11.50 Microbiota transfer as treatment of GvHD C. Högenauer, Graz
12.10 Diagnosis and treatment of gastrointestinal GvHD E. Holler, Regensburg
12.30 Panel Discussion: R. Chakraverty, London; H. Greinix, Graz; G.R. Hill, Brisbane; C. Högenauer, Graz; E. Holler, Regensburg; P.R. Reddy, Ann Arbor; M.R.M. van den Brink, New York
12.50 Summary and closing remarks E. Holler, Regensburg
13.00 Lunch
9
List of Speakers, Moderators and Scientific Organizers
Dr. Marie-Charlotte BrueggenDepartment of DermatologyUniversity Hospital ZurichGloriastrasse 318091 Zü[email protected]
Prof. Dr. Ronjon ChakravertyInst. of Immunity, Transplant.and Cancer School of MedicineRoyal Free HospitalRowland Hill StreetLondon NW3 2PFGreat [email protected]
Prof. Dr. Matthias EdingerKlinik für Innere Medizin IIIUniversitätsklinikum RegensburgFranz-Josef-Strauß-Allee 1193053 [email protected]
Sharon Elad, DMD, MScProfessor of DentistryDivision of Oral MedicineEastman Institute for Oral HealthUniversity of Rochester Medical Center625 Elmwood Ave.Rochester, NY [email protected]
James L. M. Ferrara, M.D.Professor of MedicineHematologic MalignanciesTranslational Research CenterThe Tisch Cancer InstituteDivision of Hematology / Medical OncologyHess Center for Science and Medicine1470 Madison Avenue, 6th FloorNew York, NY [email protected]
Prof. Dr. Armin GerbitzAllogeneic Stem Cell TransplantationDep. of Hematology/OncologyCharité CVK I Mittelallee 1113353 [email protected]
Prof. Dr. Hildegard GreinixKlinische Abteilung für HämatologieMedizinische Universität GrazLKH-Univ. Klinikum GrazAuenbruggerplatz 38 8036 [email protected]
PD Dr. Jörg HalterHämatologieDepartment of MedicineUniversitätsspital BaselPetersgraben 44031 [email protected]
Prof. Dr. Wolfgang HerrKlinik für Innere Medizin IIIUniversitätsklinikum RegensburgFranz-Josef-Strauß-Allee 1193053 [email protected]
Gerhard C. Hildebrandt, M.D.Professor of MedicineDivision of Hematology &Blood and Marrow TransplantationUniversity of Kentucky800 Rose StreetLexington, KY [email protected]
10
Prof. Dr. Geoffrey R. HillBone Marrow Transplantation LaboratoryQIMR Berghofer Medical Research Institute300 Herston RdBrisbane, QLD [email protected]
Prof. Dr. Christoph Högenauer Division of Gastroenterology and HepatologyDepartment of Internal MedicineMedical University of GrazAuenbruggerplatz 158036 [email protected]
Prof. Dr. Ernst HollerKlinik für Innere Medizin IIIUniversitätsklinikum RegensburgFranz-Josef-Strauß-Allee 1193053 [email protected]
Dr. Anita LawitschkaSCT-OUTPATIENT CLINICSt. Anna Children‘s HospitalKinderspitalgasse 6 1090 [email protected]
Prof. Dr. Marinka Mravak-Stipetic Clinical Department of Oral MedicineUniversity Hospital Centre Zagreb University of ZagrebGunduliceva 510000 [email protected]
Steven Z. Pavletic, M.D.Head of GvHD and Autoimmunity UnitExperimental Transplantation and Immunology BranchNational Cancer Institute10 Center DriveBethesda, MD [email protected]
Pavan R. Reddy, M.D.Div. of Hematology/OncologyDept. of Internal MedicineS.C. Mott Children‘s Hospital1540 E. Hospital Dr - SPC 4257Ann Arbor, MI [email protected]
Marcel R. M. van den Brink, M.D., Ph.D.Professor of Medicine and ImmunologyDivision of Hematologic OncologyWeill Cornell Medical College1275 York Avenue, Box 111New York, NY [email protected]
PD Dr. Eva M. WagnerIII. Medizinische KlinikUniversitätsmedizin der Johannes Gutenberg-Universität Langenbeckstr. 155131 Mainz [email protected]
Dr. Daniela WeberKlinik für Innere Medizin IIIUniversitätsklinikum RegensburgFranz-Josef-Strauß-Allee 1193053 [email protected]
11
Prof. Dr. Thomas WinklerSektion HämatopoeseLehrstuhl GenetikNikolaus-Fiebiger-Zentrum Molekulare MedizinGlueckstrasse 691054 [email protected]
Prof. Dr. Daniel WolffKlinik für Innere Medizin IIIUniversitätsklinikum RegensburgFranz-Josef-Strauß-Allee 1193053 [email protected]
Prof. Dr. Robert ZeiserKlinik für Innere Medizin ISchwerpunkt Hämatologie, Onkologieund StammzelltransplantationUniversitätsklinikum FreiburgHugstetter Str. 5579106 [email protected]
12
General InformationPrior to the opening of the Workshop in Regensburg
Falk Foundation e.V. Telephone: +49 (0)761/1514-125Congress Department Telefax: +49 (0)761/1514-359Leinenweberstr. 5 E-mail: [email protected] FreiburgGermany
Congress Office and RegistrationDuring the Workshop in Regensburg
Congress Office Telephone: +49 (0)175/7795327
Opening Hours:Friday, November 17, 2017 11.45 – 18.30 hSaturday, November 18, 2017 8.00 – 13.00 h
University Hospital RegensburgFranz-Josef-Strauss-Allee 1193053 RegensburgGermany
Congress FeesThe participation at the Workshop is free of charge. Please be aware that the number of participants is limited. Registration is mandatory.
Refreshments during the coffee breaks and lunch on November 17 – 18 and a copy of the abstract volume of the Workshop are also free of charge.
The event shall be held regardless of any decisions made by you or by your place of employment regarding the procurement, prescription or use of any products of our organization or associated companies. If you are a civil servant or salaried employee, please check whether you require permission from your employer to participate in the event. If you participate in the event, Falk Foundation e.V. presumes that you were granted permission from your employer prior to your participation.
13
Admission to Scientific EventsFor admission to scientific program your name badge should be clearly visible.
Conflicts of InterestMembers of the scientific committee declare following potential Conflicts of Interest: Daniel Wolff: Falk Pharma, Mallinckrodt; Hildegard Greinix: Incyte, Roche, Therakos Inc, Novartis, BMS; Ernst Holler: Incyte, Novartis, JAZZ Pharma, Neovii, Astellas.Jörg Halter, Wolfgang Herr, Gerhard C. Hildebrand and Steven Z. Pavletic declare no Conflicts of Interest.
Hotel Accommodation If you would like to do a hotel reservation, please contact:
Tourist-Information Altes RathausRathausplatz 493047 RegensburgGermany Tel: +49 (0)941/507-4410Tel: +49 (0)941/507-4418E-Mail: [email protected]
Airport International Franz-Josef-Strauß-Airport Munich
14
Directions to University Hospital Regensburg
Main Entrance
Universitätsklinikum Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg
HALF A CENTURY OF PROMOTING MEDICAL EXCHANGEConferences that advance medicine and re-search: 50 years ago, Herbert Falk, MD, PhD, organized a week-long event in Freiburg devot-ed to the liver – it was his first symposium and the start of an extraordinary success story.Since then, 207 additional events have been held worldwide, featuring speakers who are pioneers in their fields. To date, more than 130,000 physicians and researchers from around the world have participated in our sym-posia, and the strong interest in our upcoming events shows that this concept remains appeal-ing. We take great pride in this! Since the very beginning, all of our events – whether large or small – have been based on the principle of providing neutral continuing medical education
that benefits research, treatment, and ultimate-ly the patient.We would like to offer our deepest thanks to everyone who has participated, and we look forward to further advancing scientific dialogue as we continue to advocate for more knowledge sharing and therapeutic progress!Allow us to welcome you to the Falk Foundation symposia – now and for many years to come!
Scientific Dialogue in the Interest of Therapeutic Progress
OF SYMPOSIAYears
PWSR
EG17
2-1
1/20
17/2
00
Stü
Organized by:
FALK FOUNDATION e.V.Leinenweberstr. 579108 FreiburgGermany
Congress DepartmentTelephone: +49 (0) 761/15 14-125Telefax: +49 (0) 761/15 14-359E-Mail: symposia@falk-foundation-symposia.orgwww.falk-foundation-symposia.org